Michael Camilleri MDConsultant in the Division of Gastroenterology and Hepatology in the Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota
Michael Camilleri, M.D., is a consultant in the Division of Gastroenterology and Hepatology in the Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota. He was recognized with the Atherton and Winifred W. Bean Professorship in 2001 and as a Mayo Distinguished Investigator in 2008. He holds the ranks of Professor of Medicine, Pharmacology, and Physiology at Mayo Clinic College of Medicine. He joined the staff of Mayo Clinic in 1990. He currently serves as Executive Dean for the Department of Development at Mayo Clinic. He is the immediate past-president of the American Gastroenterological Association Institute and currently serves as chair of the American Gastroenterological Association. He has served as Chair of the Food and Drug Administration’s Gastrointestinal Drugs Advisory Committee and as a member of study sections of NIDDK at National Institutes of Health.
Dr. Camilleri received his M.D. degree from University of Malta Medical School and completed residency at St. Luke’s University Hospital in Malta. He pursued fellowships in research and internal medicine and gastroenterology at Hammersmith Hospital at the University of London, England. He completed fellowships at Mayo Graduate School in both research and clinical studies in gastroenterology. His research interests include clinical enteric neurosciences, gut neurohormonal control, obesity, irritable bowel syndrome, and pharmacology and pharmacogenomics. Formerly, he was editor of Clinical Gastroenterology and Hepatology and of Neurogastroenterology and Motility, and was associate editor of Gastroenterology. He is currently an associate editor of American Journal of Physiology. He has published extensively in high-impact scientific journals such as New England Journal of Medicine, Gastroenterology, American Journal of Physiology, Neurogastroenterology and Motility, Gut, and American Journal of Gastroenterology.
Recent Contributions to PracticeUpdate:
- Fecal Transplants Do Not Reduce Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome
- Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Cross-Over Trial
- Prevalence and Benefit of Cannabinoid Use in Gastroparesis
- Assessment of Endoscopic Full-Thickness Muscle Biopsy for Rectal Tissue Sampling in Gut Motility Disorders
- Outcomes of a Low FODMAP Diet in Patients With Irritable Bowel Syndrome and Diarrhea
- Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea
- Relamorelin and Gastric Motor Function and Satiation